28 records – page 1 of 2.

Select Title Policy Type Year
EspAddText
EspRemoveText
Antimicrobial Resistance (AMR) Policy document 2019
EspAddText
EspRemoveText
Appropriateness in health care Policy document 2020
EspAddText
EspRemoveText
CMA Statement on Racism Policy document 2020
EspAddText
EspRemoveText
Complementary and alternative medicine (update 2015) Policy document 2015
EspAddText
EspRemoveText
Concussion in Sport, Leisure, and Occupational Settings Policy document 2019
EspAddText
EspRemoveText
Consultation on proposed front-of-package labelling Response to consultation 2018
EspAddText
EspRemoveText
Consultation on the renewal of Federal Tobacco Control Strategy Response to consultation 2017
EspAddText
EspRemoveText
Firearms Control (Update 2021) Policy document 2021
EspAddText
EspRemoveText
Framework for Ethical Decision Making During the Coronavirus Pandemic Policy document 2020
EspAddText
EspRemoveText
Front-of-package labelling consultation Response to consultation 2016
EspAddText
EspRemoveText
Health and health care for an aging population Policy document 2018
EspAddText
EspRemoveText
Health Canada consultation on potential market for cannabis health products that would not require practitioner oversight Response to consultation 2019
EspAddText
EspRemoveText
Health Canada consultation on proposed vaping products promotion regulations Response to consultation 2020
EspAddText
EspRemoveText
Health Canada consultation on the impact of vaping products advertising on youth and non-users of tobacco products Response to consultation 2019
EspAddText
EspRemoveText
Health Canada consultation on tobacco products regulations (plain and standardized appearance) Response to consultation 2018
EspAddText
EspRemoveText
Health Canada consultation on vaping products labelling and packaging regulations Response to consultation 2019
EspAddText
EspRemoveText
Health Canada’s consultation on new health-related labelling for tobacco products Response to consultation 2018
EspAddText
EspRemoveText
Health Canada’s Consultation on “Plain and Standardized Packaging” Response to consultation 2016
EspAddText
EspRemoveText
Implementation of National Pharmacare Response to consultation 2018
EspAddText
EspRemoveText
Insite: CMA submission regarding Insite supervised injection site and program. Court submission 2011

28 records – page 1 of 2.